Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17 USD | +3.16% |
|
+1.31% | -26.18% |
05-30 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
05-20 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.18% | 1.97B | |
+26.53% | 89.18B | |
-26.34% | 76.11B | |
+1.62% | 27.11B | |
-10.06% | 17.13B | |
-0.14% | 16.83B | |
-0.42% | 15.4B | |
+75.58% | 13.68B | |
+81.86% | 13.25B | |
-25.79% | 12.83B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Transcript : Privia Health Group, Inc., Q4 2022 Earnings Call, Feb 28, 2023